Long-Term Services and Supports (LTSS) Policy Lab: Using Data to Drive Public Policy and Funding Decisions
UMass Chan AffiliationsCommonwealth Medicine, Center for Health Policy and Research
Commonwealth Medicine, Data Management
Document TypeWhite Paper
KeywordsLong-Term Services and Supports (LTSS) Policy Lab
elder care services
elders and aging
Health Law and Policy
Health Services Administration
Health Services Research
MetadataShow full item record
AbstractThe unprecedented growth in the elder population will create a marked increase in the demand for quality long-term services and supports (LTSS) in the Commonwealth. For low-income elders who have limited assets, the cost of these services – including home- and community-based services (HCBS) and nursing home stays – will be borne primarily by MassHealth, the state’s Medicaid program. Policy makers, executive-level leaders, and program managers need to plan for the expanded service needs of this population while also addressing the cost of services that threatens to be unsustainable. The LTSS Policy Lab, a collaboration among the University of Massachusetts Medical School, the Executive Office of Health and Human Services, the Executive Office of Elder Affairs, and the Office of Medicaid, is a resource to aid in program planning and fiscal forecasting, not just for the immediate budget cycle but also for the next five to 10 years and beyond.
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/26867
Client/Partner: Executive Office of Health and Human Services
Showing items related by title, author, creator and subject.
Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017Garcia, Maria M.; Lenz, Kimberly J.; Greenwood, Bonnie C.; Angelini, Michael C.; Thompson, Tyson; Clements, Karen M.; Mauro, Rose; Jeffrey, Paul L. (2019-08-01)Policies that address opioid dose limits may help to decrease high-risk opioid prescribing. We evaluated 3 sequential and progressive decreases in high-dose (HD) opioid limits implemented by Massachusetts Medicaid over 15 years. The study population included members ages 18 to 64 years with > /=1 claim for a schedule II opioid between January 2002 and March 2017. The 3 interventions consisted of prior authorization requirements for prescriptions exceeding the morphine equivalent dose (MED) HD dose limits: > 360 mg (intervention 1a and 1b), > 240 mg (intervention 2), and > 120 mg (intervention 3). A segmented regression evaluated the change in natural log of the average daily MED (AD_MED). The natural log of the AD_MED decreased during the 6 quarters after intervention 1a (P < .001), immediately after intervention 1b (P=.0002), and continued to decrease over the following 8 quarters (P=.023). The natural log of the AD_MED decreased immediately after intervention 2 (P=.002) and again after intervention 3 (P < .001). The percentage of users exceeding the HD limits of 360 mg, 240 mg, and 120 mg MED decreased by 87.3%, 79.8%, and 75.2% from baseline, respectively. The natural log of the AD_MED decreased among members after implementation of 3 sequential and progressive HD prior authorization limits, as did the percentage of members exceeding each of the HD limits. PERSPECTIVE: This study demonstrates the longitudinal impact of a prior authorization policy-based HD limit in a Medicaid population. This study contributes to options for policymakers and other Medicaid programs as a potential strategy to assist in addressing the opioid epidemic.
UPDATED MassHealth: The Basics - Facts, Trends and National ContextSeifert, Robert W.; Russell, Kate (2014-04-03)UPDATED chart pack, prepared by the Center for Health Law and Economics at the UMass Medical School, including summary data on MassHealth enrollment and spending. Designed to support use of the charts in presentations. Updated edition includes MassHealth enrollment as of December 31, 2013 and spending from FY 2013.
Vermont Price Variation AnalysisLondon, Katharine; Grenier, Michael G. (2014-08-31)This analysis documents price variations across the state and suggests a process and methodology that the Vermont Green Mountain Care Board could use to set standard rates. The report determined that inpatient prices among Vermont's 14 hospitals and Dartmouth-Hitchcock Medical Center in New Hampshire vary from 71 to 130 percent of the state average. The analysis identified a number of factors that explain some variation in professional prices among providers and also showed there is no consistency in the share of variation explained by each factor across health services.